Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.

Juan Berenguer,María Jesús Pérez-Elías,José María Bellón,Hernando Knobel,Rivas González P,J. M. Gatell,Miguélez M,José Hernández Quero,Juan Flores,Soriano,Ignacio Santos,Daniel Podzamczer,Sala M,Camba M,Salvador Resino,Lamivudine Spanish Abacavir

Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort.

2006

Juan Berenguer
María Jesús Pérez-Elías
José María Bellón
Hernando Knobel
Rivas González P
J. M. Gatell
Miguélez M
José Hernández Quero
Juan Flores
Soriano
Ignacio Santos
Daniel Podzamczer
Sala M
Camba M
Salvador Resino
Lamivudine Spanish Abacavir

Objective:To analyze the safety and effectiveness of abacavir, lamivudine, and zidovudine (ABC/3TC/ZDV) in antiretroviral therapy (ART)-naive HIV-infected patients.Design:Retrospective observational cohort study.Methods:We analyzed all consecutive ART-naive HIV-infected patients who initiated ABC/3T

Keywords:

Abacavir/Lamivudine
Abacavir
Virology
Cohort
Observational study
Immunology
Pharmacotherapy
Medicine
Lamivudine
Sida
Zidovudine
Hazard ratio
Interquartile range
Regimen
Viral load

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations